Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

72 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Use of a mouse model of pancreatic neuroendocrine tumors to find pericyte biomarkers of resistance to anti-angiogenic therapy.
Franco M, Pàez-Ribes M, Cortez E, Casanovas O, Pietras K. Franco M, et al. Among authors: casanovas o. Horm Metab Res. 2011 Nov;43(12):884-9. doi: 10.1055/s-0031-1284381. Epub 2011 Sep 29. Horm Metab Res. 2011. PMID: 21960459
Sprouting strategies and dead ends in anti-angiogenic targeting of NETs.
Carrasco P, Zuazo-Gaztelu I, Casanovas O. Carrasco P, et al. Among authors: casanovas o. J Mol Endocrinol. 2017 Jul;59(1):R77-R91. doi: 10.1530/JME-17-0029. Epub 2017 May 3. J Mol Endocrinol. 2017. PMID: 28469004 Review.
Relevance of angiogenesis in neuroendocrine tumors.
Teulé A, Casanovas O. Teulé A, et al. Among authors: casanovas o. Target Oncol. 2012 Jun;7(2):93-8. doi: 10.1007/s11523-012-0217-x. Epub 2012 May 17. Target Oncol. 2012. PMID: 22592949 Review.
Therapeutic Benefit of Selective Inhibition of p110α PI3-Kinase in Pancreatic Neuroendocrine Tumors.
Soler A, Figueiredo AM, Castel P, Martin L, Monelli E, Angulo-Urarte A, Milà-Guasch M, Viñals F, Baselga J, Casanovas O, Graupera M. Soler A, et al. Among authors: casanovas o. Clin Cancer Res. 2016 Dec 1;22(23):5805-5817. doi: 10.1158/1078-0432.CCR-15-3051. Epub 2016 May 25. Clin Cancer Res. 2016. PMID: 27225693 Free PMC article.
Molecular biology of neuroendocrine tumors: from pathways to biomarkers and targets.
Capdevila J, Meeker A, García-Carbonero R, Pietras K, Astudillo A, Casanovas O, Scarpa A. Capdevila J, et al. Among authors: casanovas o. Cancer Metastasis Rev. 2014 Mar;33(1):345-51. doi: 10.1007/s10555-013-9468-y. Cancer Metastasis Rev. 2014. PMID: 24375391 Review.
New drug development in digestive neuroendocrine tumors.
Durán I, Salazar R, Casanovas O, Arrazubi V, Vilar E, Siu LL, Yao J, Tabernero J. Durán I, et al. Among authors: casanovas o. Ann Oncol. 2007 Aug;18(8):1307-13. doi: 10.1093/annonc/mdm009. Epub 2007 Feb 13. Ann Oncol. 2007. PMID: 17301070 Review.
Molecular pathogenesis of neuroendocrine tumors: implications for current and future therapeutic approaches.
Oberg K, Casanovas O, Castaño JP, Chung D, Delle Fave G, Denèfle P, Harris P, Khan MS, Kulke MH, Scarpa A, Tang LH, Wiedenmann B. Oberg K, et al. Among authors: casanovas o. Clin Cancer Res. 2013 Jun 1;19(11):2842-9. doi: 10.1158/1078-0432.CCR-12-3458. Epub 2013 Mar 4. Clin Cancer Res. 2013. PMID: 23459719 Review.
Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination.
Anderberg C, Cunha SI, Zhai Z, Cortez E, Pardali E, Johnson JR, Franco M, Páez-Ribes M, Cordiner R, Fuxe J, Johansson BR, Goumans MJ, Casanovas O, ten Dijke P, Arthur HM, Pietras K. Anderberg C, et al. Among authors: casanovas o. J Exp Med. 2013 Mar 11;210(3):563-79. doi: 10.1084/jem.20120662. Epub 2013 Feb 11. J Exp Med. 2013. PMID: 23401487 Free PMC article.
Angiogenesis and Metabolism: Entwined for Therapy Resistance.
Jiménez-Valerio G, Casanovas O. Jiménez-Valerio G, et al. Among authors: casanovas o. Trends Cancer. 2017 Jan;3(1):10-18. doi: 10.1016/j.trecan.2016.11.007. Epub 2016 Dec 26. Trends Cancer. 2017. PMID: 28718423 Review.
72 results
Jump to page